4.5 Article

Neuromuscular junction denervation and terminal Schwann cell loss in the hTDP-43 overexpression mouse model of amyotrophic lateral sclerosis

Related references

Note: Only part of the references are listed.
Article Clinical Neurology

Data-driven neuropathological staging and subtyping of TDP-43 proteinopathies

Alexandra L. Young et al.

Summary: Through data-driven disease progression modelling, a fine-grained empirical staging system for TAR DNA-binding protein-43 (TDP-43) proteinopathies has been established, which can accurately classify frontotemporal lobar degeneration due to TDP-43 (FTLD-TDP), amyotrophic lateral sclerosis (ALS) and limbic-predominant age-related TDP-43 encephalopathy neuropathologic change (LATE-NC). The study reveals substantial heterogeneity in the progression patterns of ALS and FTLD-TDP, and highlights the need for further investigation in larger cross-cohort studies.

BRAIN (2023)

Review Anatomy & Morphology

Small junction, big problems: Neuromuscular junction pathology in mouse models of amyotrophic lateral sclerosis (ALS)

Abrar Alhindi et al.

Summary: Amyotrophic lateral sclerosis (ALS) is a motor neuron disease with a heterogeneous clinical and genetic phenotype, and mouse models have shown variable disease progression at the neuromuscular junction (NMJ). Models with SOD1, TARDBP, and FUS mutations exhibit early NMJ dysfunction as a common factor, while C9ORF72 models do not follow the same pattern. Further study into the timing of NMJ pathology in newer ALS mouse models will confirm its pivotal role in ALS pathogenesis.

JOURNAL OF ANATOMY (2022)

Article Medicine, General & Internal

Targeting phosphoglycerate kinase 1 with terazosin improves motor neuron phenotypes in multiple models of amyotrophic lateral sclerosis

Helena Chaytow et al.

Summary: The study demonstrates that modulating the activity of the glycolysis enzyme PGK1 can improve motor neuron function in models of amyotrophic lateral sclerosis (ALS). Treatment with terazosin, which increases PGK1 activity, extends survival, improves motor phenotypes, and protects against oxidative stress-induced cell death. This research provides a new potential approach for ALS therapy.

EBIOMEDICINE (2022)

Article Clinical Neurology

Early Axonal Dysfunction of the Peripheral Nervous System Influences Disease Progression of ALS: Evidence From Clinical Neuroelectrophysiology

Huiyan Yu et al.

Summary: The study aimed to evaluate the prognostic value of CMAP-12 amplitude for survival in ALS patients. Results indicated that decreased CMAP-12 amplitude was associated with shorter survival time and early axonal dysfunction of the peripheral nervous system may accelerate disease progression in ALS.

FRONTIERS IN NEUROLOGY (2021)

Article Clinical Neurology

Terminal Schwann cells at the human neuromuscular junction

Abrar Alhindi et al.

Summary: This study compared and analyzed terminal Schwann cells at the human and mouse neuromuscular junction, finding significant morphological and synaptic relationship differences between human and mouse terminal Schwann cells. These differences should be taken into account when translating findings from rodent models to human neuromuscular junction biology and pathology.

BRAIN COMMUNICATIONS (2021)

Article Medicine, Research & Experimental

Neuromuscular junctions are stable in patients with cancer cachexia

Ines Boehm et al.

JOURNAL OF CLINICAL INVESTIGATION (2020)

Article Multidisciplinary Sciences

aNMJ-morph: a simple macro for rapid analysis of neuromuscular junction morphology

Gavin Minty et al.

ROYAL SOCIETY OPEN SCIENCE (2020)

Review Clinical Neurology

Amyotrophic lateral sclerosis: a clinical review

P. Masrori et al.

EUROPEAN JOURNAL OF NEUROLOGY (2020)

Article Anatomy & Morphology

Morphological variability is greater at developing than mature mouse neuromuscular junctions

Aleksandra M. Mech et al.

JOURNAL OF ANATOMY (2020)

Review Neurosciences

Molecular Mechanisms of TDP-43 Misfolding and Pathology in Amyotrophic Lateral Sclerosis

Archana Prasad et al.

FRONTIERS IN MOLECULAR NEUROSCIENCE (2019)

Review Neurosciences

Clinical relevance of terminal Schwann cells: An overlooked component of the neuromuscular junction

Katherine B. Santosa et al.

JOURNAL OF NEUROSCIENCE RESEARCH (2018)

Article Cell Biology

Cellular and Molecular Anatomy of the Human Neuromuscular Junction

Ross A. Jones et al.

CELL REPORTS (2017)

Review Biochemistry & Molecular Biology

Molecular neuropathology of frontotemporal dementia: insights into disease mechanisms from postmortem studies

Ian R. A. Mackenzie et al.

JOURNAL OF NEUROCHEMISTRY (2016)

Article Clinical Neurology

Endplate denervation correlates with Nogo-A muscle expression in amyotrophic lateral sclerosis patients

Gaelle Bruneteau et al.

ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2015)

Article Genetics & Heredity

TARDBP and FUS Mutations Associated with Amyotrophic Lateral Sclerosis: Summary and Update

Serena Lattante et al.

HUMAN MUTATION (2013)

Article Multidisciplinary Sciences

ALS-linked TDP-43 mutations produce aberrant RNA splicing and adult-onset motor neuron disease without aggregation or loss of nuclear TDP-43

Eveline S. Arnold et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)

Article Biochemistry & Molecular Biology

Sustained Expression of TDP-43 and FUS in Motor Neurons in Rodent's Lifetime

Cao Huang et al.

International Journal of Biological Sciences (2012)

Review Neurosciences

Motor Neuron Diversity in Development and Disease

Kevin C. Kanning et al.

ANNUAL REVIEW OF NEUROSCIENCE, VOL 33 (2010)

Article Biochemistry & Molecular Biology

SAHA ameliorates the SMA phenotype in two mouse models for spinal muscular atrophy

Markus Riessland et al.

HUMAN MOLECULAR GENETICS (2010)

Article Biochemistry & Molecular Biology

TDP-43 Is a Developmentally Regulated Protein Essential for Early Embryonic Development

Chantelle F. Sephton et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2010)

Article Cell Biology

Specific proteolytic cleavage of agrin regulates maturation of the neuromuscular junction

Marc F. Bolliger et al.

JOURNAL OF CELL SCIENCE (2010)

Article Multidisciplinary Sciences

TDP-43 transgenic mice develop spastic paralysis and neuronal inclusions characteristic of ALS and frontotemporal lobar degeneration

Hans Wils et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)

Article Clinical Neurology

Early detachment of neuromuscular junction proteins in ALS mice with SODG93A mutation

Hisashi Narai et al.

NEUROLOGY INTERNATIONAL (2009)

Article Multidisciplinary Sciences

TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis

Jemeen Sreedharan et al.

SCIENCE (2008)

Article Biochemistry & Molecular Biology

TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis

Tetsuaki Arai et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)

Article Multidisciplinary Sciences

Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis

Manuela Neumann et al.

SCIENCE (2006)

Article Neurosciences

Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man

LR Fischer et al.

EXPERIMENTAL NEUROLOGY (2004)